natgillin/translations-raw huggingface dataset:
poudarja, da je treba sprejeti posebne ukrepe za redke in manj običajne vrste raka, da se pospeši diagnosticiranje in zagotovi širša dostopnost strokovnega znanja v centrih odličnosti;
Stresses that special action is to be taken for rare and less common cancers, with the aim of accelerating diagnosis and making expertise more widely available in centres of excellence;
poudarja, da lahko v skladu z Lizbonsko pogodbo tudi Evropski parlament in Svet – po rednem zakonodajnem postopku in po posvetovanju z Ekonomsko-socialnim odborom ter Odborom regij – sprejmeta spodbujevalne ukrepe za varstvo in izboljšanje človekovega zdravja;
Points out that according to the Lisbon Treaty the European Parliament and the Council, acting in accordance with the ordinary legislative procedure and after consulting the Economic and Social Committee and the Committee of the Regions, may also adopt incentive measures designed to protect and improve human health;
meni, da je uspeh partnerstva odvisen od optimalne uporabe razpoložljivih sredstev glede na to, da do konca sedanjega finančnega okvira (2013) ni predvidenega dodatnega financiranja;
Considers that the success of the partnership, given the absence of additional funding before the end of the current financial framework (2013), depends on making optimum use of the available resources;
poziva države članice, naj čim prej oblikujejo celovite načrte v zvezi z rakom, saj so ključ do uresničenja ambiciozno zastavljenega dolgoročnega cilja partnerstva, da bi do leta 2020 breme raka zmanjšali za 15 odstotkov;
Calls on Member States to set up integrated cancer plans as soon as possible as these are key to achieving the Partnership's ambitious long-term aim of reducing the burden of cancer by 15% by 2020;
poziva Komisijo, naj se v zvezi z načrti za nadzor raka opre na ugotovitve partnerstva za preprečevanje in zdravljenje raka ter predloži predlog priporočila Sveta o načrtih za nadzor raka; poziva Komisijo, naj na letni ravni neodvisno spremlja izvajanje in napredek sprejetega priporočila;
Calls on the Commission to build on findings of the Cancer Partnership with regard to cancer control plans and to present a proposal for a Council Recommendation on Cancer Control Plans; calls on the Commission to monitor independently on a yearly basis the implementation and progress of the recommendation adopted;
poziva partnerstvo, naj zagotovi, da skupinski ukrepi „spodbujanja zdravja in preprečevanja“ in „raziskave“ vključujejo element okoljskih dejavnikov, katerih opredelitev ne zajema le tobačnega dima iz okolja, sevanja in prekomerne izpostavljenosti UV-žarkom, ampak tudi nevarne kemikalije v zaprtih prostorih in na prostem, ki so jim ljudje izpostavljeni, vključno z endokrinimi motilci;
Calls upon the Partnership to ensure that all ‘Health Promotion and Prevention’ and ‘Research’ group actions include a component on environmental factors, these being defined as not only environmental tobacco smoke, radiation, and excessive UV exposure, but also hazardous chemicals in the indoor and outdoor environment to which people are exposed, including endocrine disruptors;
meni, da je obravnavanje „dejavnikov tveganja“ raka ključno za njegovo preprečevanje, in poziva države članice, naj to upoštevajo kot prednostno nalogo;
Considers that tackling ‘risk factors’ for cancer is key to prevention and urges Member States to treat this as a priority;
poudarja, da se je treba pri naraščajočem številu kroničnih bolnikov, pri katerih bolezni ni mogoče pozdraviti, jo je pa mogoče za več let stabilizirati, vse bolj osredotočiti na kakovost življenja;
Highlights that there is an increasing need to focus on the quality of life for a rising number of chronic cancer patients whose illness cannot be cured but which may be stabilised for a number of years;
poudarja, da bi morali ukrepi, osredinjeni v zmanjševanje razlik glede bremena raka, zajemati usmerjeno spodbujanje zdravja, izobraževanje javnosti in programe preprečevanja ter zbiranje podatkov iz nacionalnih registrov za primere raka med prebivalstvom, ter primerljive, popolne in točne podatke o rakavih obolenjih iz registrov;
Stresses that actions aimed at reducing inequities in the cancer burden should include targeted promotion of health, public education and prevention programmes as well as the collection of data from population-based national cancer registries and comparable, complete and accurate registry data on cancer;
poziva Komisijo, naj spodbuja države članice z visoko stopnjo umrljivosti zaradi raka, naj preoblikujejo svoje nacionalne registre, da bodo zbrale podatke, ki so potrebni za bolj ozaveščene in osredotočene politike;
Urges the Commission to encourage those Member States with high cancer mortality to reform their national cancer registries in order to provide the data necessary for better informed and more focused policies;
odločno poziva, naj partnerstvo EU za preprečevanje in zdravljenje raka in prihodnje pobude EU, kakršna je revidirano priporočilo Sveta o zgodnjem odkrivanju raka, poleg spodbujanja zdravja ter boja proti preveliki telesni teži in uživanju alkohola obravnavajo preprečevanje in nadzor bolezni, ki se lahko razvijejo v rakava obolenja, na primer primarno in sekundarno preprečevanje virusnega hepatitisa ter po potrebi njegovo zdravljenje;
Urges that, apart from health promotion and the fight against excessive weight and alcohol consumption, the prevention and control of diseases which can develop into cancer, for instance primary and secondary prevention of viral hepatitis and treatment where appropriate, should be addressed by the Cancer Partnership and in future EU initiatives, such as a revised Council recommendation on cancer screening;
poudarja vlogo presejanja kot enega najpomembnejših instrumentov v boju proti raku; poziva države članice, naj vlagajo v programe presejanja za odkrivanje raka, in meni, da so te pobude najučinkovitejše, če so redno na voljo najširšemu možnemu krogu ljudi;
Stresses the role of screening as one of the most important instruments in the fight against cancer; urges Member States to invest in cancer screening programmes and considers that these initiatives are most efficient when they are available to the widest possible range of people and on a regular basis;
poudarja, da bi bilo treba razviti celovite (osnovne in klinične) raziskave o uporabi prehrane pri preprečevanju raka in zdravljenju neprimerne prehranjenosti, povezane z rakavimi obolenji, pa tudi ocenjene in splošno sprejete smernice o prehrambeni podpori za bolnike z rakom; zato poziva Komisijo, naj zagotovi financiranje za razvoj in potrditev celovitega raziskovanja (osnovnega in kliničnega) o uporabi prehrane pri preprečevanju raka in zdravljenju neprimerne prehranjenosti, povezane z rakavimi obolenji, ter za razvoj splošno sprejetih smernic o prehrambeni podpori za bolnike z rakom za strokovnjake na socialnem in zdravstvenem področju po vsej Evropi, in poziva države članice, naj spodbujajo izvajanje teh smernic;
Stresses that integrated research (basic and clinical) on the use of nutrition in preventing cancer and treating malnutrition associated with cancer, as well as validated and widely accepted guidelines on nutritional support for cancer patients, should be developed; urges therefore the Commission to provide funding to develop and validate integrated research (basic and clinical) on the use of nutrition in preventing cancer and treating malnutrition associated with cancer, as well as for the development of widely accepted guidelines on nutritional support for cancer patients for social and health care professionals across Europe, and calls on the Member States to promote the implementation of such guidelines;
poudarja, da je treba evropski kodeks proti raku pregledati ter širše in odločneje razširiti po vsej EU-27, v sklopu partnerstva EU za preprečevanje in zdravljenje raka pa je treba ta prizadevanja posebej usmeriti v nove države članice;
Stresses that the European Code Against Cancer needs to be revised and promoted more widely and forcefully across the EU-27 and that particular efforts should be directed towards new Member States under the European Cancer Partnership;
poziva države članice, naj uvedejo obvezno beleženje primerov raka s standardizirano evropsko terminologijo, da se zagotovi sredstvo za ocenjevanje programov preprečevanja, presejanja in zdravljenja ter stopenj preživetja, kakor tudi primerljivost podatkov med državami članicami, ter naj na podlagi teh ugotovitev oblikujejo informacije, namenjene širši javnosti,
Urges the Member States to establish a legal obligation to declare cancer cases, using standardised European terminology, the object being to provide means of evaluating prevention, screening, and treatment programmes, survival rates, and the comparability of data from one Member State to another and, on the basis of the findings, to produce information aimed at the general public;
poudarja, da je mogoče rakava obolenja zmanjšati in nadzirati z izvajanjem strategij za zgodnje odkrivanje, temelječih na znanstvenih dognanjih, in obravnavanjem bolnikov z rakom, vključno z ustreznimi informacijami o koristih presejalnega programa za ozaveščanje tistih oseb, ki bi jim program koristil; v zvezi s tem poziva države članice, naj preučijo, ali je koristen presejalni program za raka dojke za ženske, stare manj kot 50 in več kot 69 let, in poziva Komisijo, naj zbere in analizira te informacije;
Stresses that cancer can be reduced and controlled by implementing evidence-based strategies for early detection and management of patients with cancer, including appropriate information to ensure awareness of the benefits of screening for those who should benefit from it; urges the Member States in this connection to examine whether breast cancer screening for women under 50 and over 69 years of age serves a useful purpose and asks the Commission to collect and analyse this information;
poudarja, da se je nujno treba dogovoriti o standardih za kakovostno zdravljenje rakavih obolenj pri otrocih ter jih razširiti in uporabljati v vsej EU-27;
Stresses the urgent need for agreed quality treatment standards for childhood cancers to be shared and applied across the EU-27;
poziva države članice, naj si bolj prizadevajo za povečanje ozaveščenosti o vrstah raka, ki so značilne za spol, da se poveča raven preprečevanja in spodbudi presejanje za te bolezni;
Calls on Member States to do more to raise awareness of gender specific cancer, in order to increase levels of prevention and encourage screening for these diseases;
poziva Komisijo, naj v sedmem okvirnem programu za raziskave zagotovi financiranje nadaljnjega razvoja krvnih in urinskih testov (testi z biomarkerji) in upošteva, da so ti postopki za zgodnje diagnosticiranje raka obetavno sredstvo za odkrivanje različnih vrst raka (prostate, debelega črevesa, jajčnikov, ledvic in mehurja);
Calls on the Commission to provide funding for the further development of blood- and urine-based tests (biomarker tests) within the seventh Research Framework Programme, bearing in mind that these early diagnosis procedures are promising tools for detecting different types of cancer (prostate, colon, ovarian, kidney, and bladder cancer);
meni, da bi bilo treba obstoječa sredstva, ki so v sedmem okvirnem programu namenjena za boj proti raku, uporabiti učinkoviteje, na primer z boljšo usklajenostjo med različnimi centri za raziskave raka v EU;
Considers that existing FP7 funding allocated to the fight against cancer should be used more efficiently through, for example, better coordination between the different cancer research centres in the EU;
poziva Komisijo, naj v celoti izvaja svojo podporno vlogo z uvedbo skupnih ukrepov na področju raziskav;
Calls on the Commission to make full use of its supporting role by setting up joint actions on research;
poziva, naj se poveča podpora za raziskave o preprečevanju raka, med drugim tudi raziskave o učinkih škodljivih kemikalij in onesnaževal okolja, prehrani, življenjskem slogu, genetskih dejavnikih ter o medsebojnem delovanju teh dejavnikov, poziva pa tudi, naj se raziščejo povezave med rakom in morebitnimi dejavniki tveganja, na primer tobakom, alkoholom, farmacevtskimi in sintetičnimi hormoni, ki so prisotni v okolju;
Calls for support to be stepped up for research into cancer prevention, including research into the effects of harmful chemicals and environmental pollutants, nutrition, lifestyle, genetic factors, and the interaction of all these, and calls for the links between cancer and potential risk factors such as tobacco, alcohol and pharmaceutical and synthetic hormones present in the environment to be investigated;
poudarja, da češka vlada še ni ratificirala Okvirne konvencije SZO o nadzoru tobaka, ki je začela veljati februarja 2005, in jo poziva, naj to stori;
Notes that the Czech Government has not yet ratified the WHO Framework Convention on Tobacco Control, which entered into force in February 2005, and therefore urges it to do so;
poziva, da se v raziskavah biološkega spreminjanja nameni posebna pozornost najpomembnejšim virom izpostavljenosti rakotvornim snovem, zlasti prometu, izpustom iz industrije, kakovosti zraka v večjih mestih ter hlapom in površinskim vodamv bližini odlagališč odpadkov;
Calls for bio-monitoring research to pay particular attention to the most important sources of exposure to carcinogenic substances, in particular traffic, emissions from industry, air quality in large cities, and emanations and surface waters in the vicinity of waste disposal;
poziva Komisijo, naj zagotovi hitrejše ukrepanje v skladu s strategijo Skupnosti o endokrinih motilcih;
Calls upon the Commission to ensure that swifter action is taken under the Community Strategy on Endocrine Disruptors;
poudarja, da je treba ugotovitve raziskav čim prej prenesti v konkretne ukrepe in da se raziskave, ki potekajo, ne smejo uporabljati za odložitev ukrepov proti znanim ali sumljivim dejavnikom, ki povzročajo ali povečujejo pogostost rakavih obolenj;
Stresses that research findings should be translated into concrete action as soon as possible, and that ongoing research should not be used to delay action against known or suspected factors that cause or promote cancer incidence;
poziva Komisijo, naj spodbuja države članice k sprejetju politike v podporo načelom v skladu z globalno strategijo o prehrani, telesni dejavnosti in zdravju Svetovne zdravstvene organizacije, ki je bila uvedena leta 2004;
Calls on the Commission to encourage the Member States to adopt policies to support the principles embodied in the World Health Organization's Global Strategy on Diet, Physical Activity and Health launched in 2004;
meni, da je potrebno več raziskav o povezavi med rakom in spolom ter posebnih, nerazdrobljenih raziskav o vplivu delovnega okolja na raka;
Considers that more research on the connection between cancer and gender is needed as well as specific, but not fragmented, research on the impact of the working environment on cancers;
poziva Komisijo, naj na vse možne načine spodbuja načelo preprečevanja tako v zdravniški praksi kot v bolj zdravem načinu življenja ter spodbudi države članice k večjim naložbam v preprečevanje, tako primarno (izpostavljenost onesnaževalom okolja) kot sekundarno s presejanjem in zgodnjim odkrivanjem;
Calls on the Commission to promote by every possible means the principle of prevention both in medical practices and in more healthy lifestyles and to encourage Member States to invest more of their resources in prevention, both primary (i.e. preventing or reducing factors that cause or promote cancer incidence such as exposure to environmental pollutants) and secondary via screening and early detection;
meni, da je treba postopke in tehnike zgodnjega odkrivanja temeljiteje preučiti, preden se začnejo široko uporabljati, da se zagotovi njihova varna uporaba, ki bo temeljila na znanstvenih dognanjih; zato mora to raziskovanje pripeljati do nedvoumnih priporočil in smernic, ki temeljijo na znanstvenih dognanjih;
Considers that early detection procedures and techniques should be researched more thoroughly before being widely applied in order to guarantee that their use and application is safe and evidence-based; therefore, it is necessary that this research leads to unambiguous and evidence-based recommendations and guidelines;
meni, da sredstva, ki so zdaj na voljo za boj proti raku v EU, ne zadoščajo za potrebne raziskave in usklajevanje, niti za zagotovitev ustreznih informacij o preprečevanju za državljane EU;
Considers that the current funding available to fight cancer in the EU is inadequate to produce the necessary research and coordination as well as to provide decent preventive information for EU citizens;
spodbuja Komisijo, naj v finančno perspektivo vključi sredstva za spodbujanje preprečevanja raka;
Encourages the Commission to include funding to promote cancer prevention in the financial perspective;
poziva Komisijo in države članice, naj v okviru partnerstva EU za preprečevanje in zdravljenje raka vzpostavijo evropsko mrežo za preprečevanje, ki bo obravnavala vse dejavnike zdravja, ki so pomembni za raka, tudi okoljske;
Calls on the Commission and Member States to set up a European Network for Prevention under the European Cancer Partnership that addresses all health determinants relevant for cancer, including environmental ones;
poziva Komisijo, naj spodbuja in podpira pobude, ki vključujejo širok spekter zainteresiranih strani, namenjene za preprečevanje rakavih obolenj z zmanjšanjem poklicne in okoljske izpostavljenosti rakotvornim in drugim snovem, ki prispevajo k nastanku raka, ter s spodbujanjem zdravega načina življenja, nenazadnje s poudarjanjem glavnih dejavnikov tveganja, kot so tobak, alkohol, prekomerna telesna teža, nezdrav način prehranjevanja, pomanjkanje telesne dejavnosti in izpostavljenost soncu, s poudarkom na otrocih in najstnikih;
Calls on the Commission to encourage and support initiatives bringing together a wide range of stakeholders with the aim of preventing cancer by reducing occupational and environmental exposure to carcinogens and other cancer-producing substances and by promoting healthy lifestyles, not least by highlighting the main risk factors such as tobacco, alcohol, obesity, poor diet, lack of exercise, and exposure to the sun, placing the emphasis first and foremost on children and teenagers;
poziva k reševanju težav, povezanih z okoljskim zdravjem, ki vplivajo na razvoj določenih vrst raka v skladu z opredelitvami v evropskem akcijskem načrtu za okolje in zdravje 2004–2010, in sicer z oceno poznejših nacionalnih akcijskih načrtov za okolje in zdravje ter sodelovanjem držav članic pri izmenjavi rezultatov, doseženih v procesu, da bodo lahko rezultati, pridobljeni v posameznih državah, spodbudili evropske ukrepe na tem področju;
Calls for the need to tackle environmental-health related problems which have impacts on the development of specific types of cancer in accordance with what has been defined under the European Environment and Health Action Plan 2004-2010, namely through the assessment of the subsequent national Environmental and Health Action Plans and through cooperation between Member States on the results achieved throughout the process, in order to guarantee that the results obtained in each country may help promote European intervention in this domain;
poudarja, da zahteva optimalna oskrba bolnika večdisciplinarni pristop, da je vloga zdravnika onkologa kot bolnikovega posrednika osrednja; da se zagotovi čim boljša usposobljenost zdravnikov, ki uporabljajo zdravila proti raku, pa so potrebni izobraževanje ter jasna merila in smernice;
Underlines that optimal patient care requires a multidisciplinary approach, that the role of medical oncologist as a patient interface is central and that education, clear criteria and guidelines are needed to ensure the optimal qualification of physicians using drugs for cancer treatment;
poziva Komisijo in partnerstvo, naj pregledata priporočilo Sveta o presejalnih pregledih za odkrivanje raka glede na najnovejši znanstveni razvoj, da se spodbudi razvoj evropskih programov za akreditacijo/certificiranje na področju preventivnih pregledov za odkrivanje, diagnosticiranje in zdravljenje raka, ki bodo temeljili na evropskih smernicah za zagotavljanje kakovosti, ob upoštevanju, da bi lahko bili taki programi zgled drugim področjem zdravstvene oskrbe;
Calls on the Commission and the Partnership to review the Council recommendation on cancer screening in the light of the latest scientific developments in order to provide encouragement for future European accreditation/certification programmes in the area of cancer screening, diagnosis, and treatment to be drawn up on the basis of the European quality assurance guidelines, bearing in mind that such programmes could also serve as an example for other healthcare fields;
poziva Komisijo in države članice, naj spodbujajo informacijske kampanje o preventivnih pregledih za odkrivanje rakavih obolenj, namenjene širši javnosti in vsem ponudnikom zdravstvenih storitev, pa tudi izmenjave najboljše prakse o uporabi ukrepov za preprečevanje ali zgodnje odkrivanje, kot so stroškovno učinkovito vključevanje ustreznega testiranja za humani papiloma virus (HPV) za zgodnje odkrivanje raka na materničnem vratu in cepljenje proti temu virusu za zaščito mladih žensk proti raku materničnega vratu, ter poziva partnerstvo EU za preprečevanje in zdravljenje raka, naj preuči, ali je treba posodobiti priporočilo Sveta o zgodnjem odkrivanju raka, da bi se lahko upoštevala dognanja o učinkovitem zgodnjem odkrivanju raka prostate pri moških;
Urges the Commission and the Member States to promote information campaigns on cancer screening directed at the general public and all healthcare providers, as well as the exchange of best practice on the use of preventive or early-detection measures, such as cost-effective integration of appropriate human papilloma virus (HPV) testing for cervical cancer screening and HPV vaccination to protect young women from cervical cancer, and asks the European Cancer Partnership to examine the need to update the Council recommendation on cancer screening to take account of evidence for effective prostate cancer screening in men;
poziva Komisijo, naj uporabi obstoječi Evropski center za preprečevanje in obvladovanje bolezni, tako da njegovim nalogam doda nenalezljive bolezni in ga uporabi kot sedež raziskav raka v EU, kjer bi lahko vse podatke, že zbrane v posameznih državah članicah, uredili in analizirali, da bi znanstvenikom in zdravnikom zagotovili primere najboljše prakse in boljše poznavanje bolezni;
Calls on the Commission to use the existing European Centre for Disease Prevention and Control (ECDC) by adding non-communicable diseases to its mandate and by using it as the headquarters for EU cancer research where all the data already collected in each Member State could be harnessed and analysed in order to provide scientists and doctors with best practices and greater knowledge of the disease;
pozdravlja predlog Komisije o evropskem partnerstvu za boj proti raku za obdobje 2009–2013 in predlog, da se zmanjša breme raka z uvedbo presejalnih programov za raka dojke, materničnega vratu in debelega črevesa za vse prebivalstvo, ter poziva države članice, naj smernice v celoti izvajajo;
Welcomes the Commission proposal on a European Partnership for Action against Cancer for the period 2009-2013 and the proposal to reduce the cancer burden by introducing 100% population screening for breast, cervical and colorectal cancers by 2013, and urges Member States to fully implement the guidelines;
poziva Komisijo, naj pripravi listino o zaščiti bolnikov z rakom in kroničnih bolnikov na delovnem mestu, da bi se lahko od podjetij zahtevalo, naj obolelim omogočijo nadaljevanje delovnega razmerja med zdravljenjem in vrnitev na trg dela po končanem zdravljenju;
Calls on the Commission to draw up a charter for the protection of the rights of cancer patients and chronically sick people in the workplace, with a view to requiring firms to make it possible for patients to continue in employment during their treatment and to return to the employment market after it has finished;